# Daridorexant for People With Insomnia and Alcohol Use Disorder Study

> **NCT07701928** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Sterling McPherson** · enrollment: 205 (estimated)

## Conditions studied

- Alcohol Use Disorder
- Insomnia

## Interventions

- **DRUG:** Daridorexant
- **DRUG:** Placebo
- **BEHAVIORAL:** Brief Counseling
- **DEVICE:** MEMS and Medication Accounting
- **BEHAVIORAL:** Contingency Management for Medication Adherence

## Key facts

- **NCT ID:** NCT07701928
- **Lead sponsor:** Sterling McPherson
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2030-12
- **Final completion:** 2031-12
- **Target enrollment:** 205 (ESTIMATED)
- **Last updated:** 2026-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701928, "Daridorexant for People With Insomnia and Alcohol Use Disorder Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*